Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications

International Journal of Pharmaceutics

Volumn 423, Issue 2, 2012, Pages 496-508

  Sievens Figueroa, Lucas ^a   Bhakay, Anagha ^a   Jerez Rozo, Jackeline I ^b   Pandya, Natasha ^a   Romañach, Rodolfo J ^b   Michniak Kohn, Bozena ^c   Iqbal, Zafar ^a   Bilgili, Ecevit ^a   Davé, Rajesh N ^a  

^a NEW JERSEY INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

BCS Class II; Hydroxylpropyl methyl cellulose; Media milling; Nanosuspensions; Pharmaceutical films

Indexed keywords

FENOFIBRATE; GRISEOFULVIN; HYDROXYPROPYLMETHYLCELLULOSE; NANOPARTICLE; NAPROXEN; POLYMER; SURFACTANT;

ARTICLE; CRYSTALLIZATION; DRUG SOLUBILITY; FEASIBILITY STUDY; HYDROGEN BOND; PARTICLE SIZE; PRIORITY JOURNAL; RAMAN SPECTROMETRY; SCANNING ELECTRON MICROSCOPY; SUSPENSION; X RAY DIFFRACTION; YOUNG MODULUS;

CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; DRUG CARRIERS; DRUG COMPOUNDING; ELASTIC MODULUS; FEASIBILITY STUDIES; FENOFIBRATE; GLYCEROL; GRISEOFULVIN; HYDROGEN BONDING; KINETICS; METHYLCELLULOSE; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; NANOTECHNOLOGY; NAPROXEN; PARTICLE SIZE; PLASTICIZERS; SOLUBILITY; SPECTROSCOPY, NEAR-INFRARED; SPECTRUM ANALYSIS, RAMAN; SURFACE PROPERTIES; SURFACE-ACTIVE AGENTS; TECHNOLOGY, PHARMACEUTICAL;

EID: 84856537441     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.12.001     Document Type: Article

References (80)

1. G.L. Amidon, H. Lennernäs, V.P. Shah, and J.R. Crison A theoretical basis for a biopharmaceutical drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability Pharm. Res. 12 1995 413 420
2. Bess, W.S., Kulkarni, N., Ambike, S.H., Ramsay, M.P., 2010. Fast dissolving orally consumable films containing a taste masking agent. US Patent 7,648,712.
3. A. Bhakay, M. Merwade, E. Bilgili, and R.N. Dave Novel aspects of wet milling for the production of microsuspensions and nanosuspensions of poorly water-soluble drugs Drug Dev. Ind. Pharm. 37 2011 963 976
4. Bhakay, A., Bilgili, E., Davé, R. Recovery of BCS Class II drug nanoparticles from core-shell type nanocomposite particles produced via fluidized bed coating. Powder Technology, under review.
5. E. Bilgili, R. Hamey, and B. Scarlett Production of pigment nanoparticles using a wet stirred media mill with polymeric media China Particuol. 2 2004 93 100
6. E. Bilgili, R. Hamey, and B. Scarlett Nano-milling of pigment agglomerates using a wet stirred media mill: elucidation of the kinetics and breakage mechanisms Chem. Eng. Sci. 61 2006 149 157 (Pubitemid 41382592)
7. J.S. Boateng, A.D. Auffret, K.H. Matthews, M.J. Humphrey, H.N.E. Stevens, and M. Gillian Characterization of freeze-dried wafers and solvent evaporated films as potential drug delivery systems to mucosal surfaces Int. J. Pharm. 389 2010 24 31
8. K. Chan, and S. Kazarian Visualization of the heterogeneous water sorption in a pharmaceutical formulation under controlled humidity via FT-IR imaging Vib. Spectrosc. 35 2004 45 49
9. W. Cheow, M. Ng, K. Kho, and K. Hadinoto Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze drying adjuvants Int. J. Pharm. 404 2011 289 300
10. J. Choi, C. Park, and J. Lee Effect of polymer molecular weight on nanocomminution of poorly soluble drug Drug Deliv. 15 2008 347 353
11. J.-Y. Choi, J.Y. Yoo, H.-S. Kwak, B.U. Nam, and J. Lee Role of polymeric stabilizers for drug nanocrystal dispersions Curr. Appl. Phys. 2005 472 474 (Pubitemid 40714976)
12. F. Cilurzo, I.E. Cupone, P. Minghetti, F. Selmin, and L. Montanari Fast dissolving films made of maltodextrins Eur. J. Pharm. Biopharm. 70 2008 895 900
13. A. de Juan, R. Tauler, R. Dyson, C. Marcolli, M. Rault, and M. Maeder Trends Anal. Chem. 23 2011 70 79
14. Desieno, M.A., Stetsko, G., 1996. Redispersible nanoparticulate film matrices with protective overcoats. US Patent 5,573,783.
15. R.P. Dixit, and S.P. Puthli Oral strip technology: overview and future potential J. Control. Release 139 2009 94 107
16. D.A. El-Setouhy, and N.S. Abd El-Malak Formulation of a novel tianeptine sodium orodispersible film AAPS Pharm. Sci. Tech. 11 2010 1018 1025
17. J. Emami In vitro-in vivo correlation: from theory to applications J. Pharm. Pharmaceut. Sci. 9 2006 31 51 (Pubitemid 43984046)
18. D. Eskin, O. Zhupanska, R. Hamey, B. Moudgil, and B. Scarlett Microhydrodynamics of stirred media milling Powder Technol. 156 2005 95 102 (Pubitemid 41207704)
19. L. Gao, D. Zhang, and M. Chen Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system J. Nanopart. Res. 10 2008 845 846
20. V. Garsuch, and J. Breitkreutz Comparative investigations on different polymers for the preparation of fast-dissolving oral films J. Pharm. Pharmacol. 62 2010 539 545
21. A. Hanafy, H. Spahn-Langguth, G. Vergnault, P. Grenier, M. Tubic Grozdanis, T. Lenhardt, and P. Langguth Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug Adv. Drug Deliv. Rev. 59 2007 419 426 (Pubitemid 47260709)
22. D. Heng, D.J. Cutler, H.-K. Chan, J. Yun, and J.A. Raper What is a suitable dissolution method for drug nanoparticles Pharm. Res. 25 2008 1696 1701
23. D. Heng, K. Ogawa, D.J. Cutler, H. Chan, J.A. Raper, L. Ye, and J. Yun Pure drug nanoparticles in tablets: what are the dissolution limitations? J. Nanopart. Res. 12 2010 1743 1754
24. N. Hernandez-Trejo, O. Kayser, H. Steckel, and R.H. Müller Characterization of nebulized buparvaquone nanosuspensions-effect of nebulization technology J. Drug Target 13 2005 499 507 (Pubitemid 43347847)
25. N. Hirasawa, K. Danjo, M. Haruna, and A. Otsuka Physicochemical characterization and drug release studies of naproxen solid dispersions using lactose as a carrier Chem. Pharm. Bull. 46 1998 1027 1030 (Pubitemid 28363332)
26. J. Hu, W. Ng, Y. Dong, S. Shen, and R. Tan Continuous and scalable process for water redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray drying Int. J. Pharm. 404 2011 198 204
27. S. Jamzad, and R. Fassihi Role of surfactant and pH on dissolution properties of fenofibrate and glipizide - a technical note AAPS Pharm. Sci. Tech. 7 2006 (article 33) http://www.aapspharmscitech.org
28. J.I. Jérez Rozo, A. Zarow, B. Zhou, R. Pinal, Z. Iqbal, and R.J. Romañach Complementary near-infrared and Raman chemical imaging of pharmaceutical thin films J. Pharm. Sci. 2011 10.1002/jps.22653 Published online in Wiley Online Library http://www.wileyonlinelibrary.com
29. M. Jug, M. Bećirević-Laćan, and S. Bengez Novel cyclodextrin-based film formulation intended for buccal delivery of atenolol Drug Dev. Ind. Pharm. 35 2009 796 807
30. M. Kakhi Classification of the flow regimes in the flow-through cell Eur. J. Pharm. Biopharm. 37 2009 531 544
31. C.M. Keck, and R.H. Muller Drug nanocrystals of poorly soluble drugs produced by high pressure homogenization Eur. J. Pharm. Biopharm. 62 2006 3 16 (Pubitemid 41736019)
32. F. Kesisoglou, S. Panmai, and Y. Wu Nanosizing-oral formulation development and biopharmaceutical evaluation Adv. Drug Deliv. Rev. 59 2007 631 644 (Pubitemid 47285408)
33. S. Kim, and J. Lee Effective polymeric dispersants for vacuum, convection and freeze drying of drug nanosuspensions Int. J. Pharm. 397 2010 218 224
34. Y.S.R. Krishnaiah Pharmaceutical technologies for enhancing oral bioavailability of poorly soluble drugs J. Bioequiv. Bioavail. 2 2010 28 36
35. J. Lee Drug nano- and microparticles processed into solid dosage forms: physical properties J. Pharm. Sci. 92 2003 2057 2068 (Pubitemid 37175635)
36. J. Lee, and Y. Cheng Critical freezing rate in freeze drying nanocrystal dispersions J. Control. Release 111 2006 185 192 (Pubitemid 43290007)
37. E.N. Lewis, J.W. Schoppelrei, E. Lee, and L.H. Kidder Near-infrared chemical imaging as a process analytical tool A.B. Katherine, Chapter 7 in Process Analytical Technology 2005 Blackwell Publishing Oxford, UK 187 225
38. H. Li, and X. Gu Correlation between drug dissolution and polymer hydration: a study using texture analysis Int. J. Pharm. 342 2007 18 25 (Pubitemid 47259317)
39. G. Liversidge, and K. Cundy Particle size reduction for the improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in Beagle dogs Int. J. Pharm. 125 1995 91 97
40. K.H. Matthews, H.N.E. Stevens, A.D. Auffret, M.J. Humphrey, and G.M. Eccleston Formulation, stability and thermal analysis of lyophilised wound healing wafers containing an insoluble MMP-3 inhibitor and a non-ionic surfactant Int. J. Pharm. 356 2008 110 120
41. R. Mauludin, R.H. Müller, and C.M. Keck Development of an oral rutin nanocrystal formulation Int. J. Pharm. 370 2009 202 209
42. S. Mende, F. Stenger, W. Peukert, and J. Schwedes Mechanical production and stabilization of submicron particles in stirred media mills Powder Technol. 132 2003 64 73 (Pubitemid 36593381)
43. L. Mendoza-Romeroa, E. Piñón-Segundo, M. Nava-Arzaluz, A. Ganem-Quintanar, S. Cordero-Sánchez, and D. Quintanar-Guerrero Comparison of pharmaceutical films prepared from aqueous polymeric dispersions using the cast method and the spraying technique Colloids Surf. A: Physicochem. Eng. Aspects 337 2009 109 116
44. E. Merisko-Liversidge, and G.G. Liversidge Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology Adv. Drug Deliv. Rev. 63 2011 427 440
45. E. Merisko-Liversidge, G.G. Liversidge, and E.R. Cooper Nanosizing: a formulation approach for poorly-water-soluble compounds Eur. J. Pharm. Sci. 18 2003 113 120 (Pubitemid 36184748)
46. R.H. Müller, J. Möschwitzer, and F.N. Bushrab Manufacturing of nanoparticles by milling and homogenization techniques R.B. Gupta, U.B. Kompella, Nanoparticle Technology for Drug Delivery, Drugs and the Pharmaceutical Sciences vol. 159 2006 Taylor & Francis Group, LLC New York 21 51
47. R.H. Muller Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect in the future Adv. Drug Deliv. Rev. 47 2011 3 19
48. R. Nair, N. Nyamweya, S. Gönen, L.J. Martínez-Miranda, and S.W. Hoag Influence of various drugs on the glass transition temperature of poly(vinylpyrrolidone): a thermodynamic and spectroscopic investigation Int. J. Pharm. 225 2001 83 96 (Pubitemid 32728202)
49. M. Nishimura, K. Matsuura, T. Tsukioka, H. Yamashita, N. Inagaki, T. Sugiyama, and T. Itoh In vitro and in vivo characteristics of prochlorperazine oral disintegrating film Int. J. Pharm. 368 2009 98 102
50. A.A. Noyes, and W.R. Whitney The rate of solution of solid substances in their own solutions J. Am. Chem. Soc. 19 1897 930 934
51. T. Panagiotou, and R.J. Fisher Form nanoparticles via controlled crystallization Chem. Eng. Prog. 2008 33 39
52. P. Pathak, M.J. Meziani, and Y.-P. Sun Supercritical fluid technology for enhanced drug delivery Expert Opin. Drug Deliv. 2 2005 747 761 (Pubitemid 41038685)
53. V.A. Perumal, D. Lutchman, I. Mackraj, and T. Govender Formulation of monolayered films with drug and polymers of opposing solubilities Int. J. Pharm. 358 2008 184 191
54. Petersen, R., 2006. Nanocrystals for use in topical cosmetic formulations and method of production thereof. US Patent 8,866,233.
55. W. Peukert, H. Schwarzer, and F. Stenger Control of aggregation in production and handling of nanoparticles Chem. Eng. Process 44 2005 245 252 (Pubitemid 39365072)
56. H. Piao, N. Kamiya, A. Hirata, T. Fujii, and M.A. Goto Novel solid-in-oil nanosuspension for transdermal delivery of diclofenac sodium Pharm. Res. 25 2008 896 901 (Pubitemid 351661840)
57. H.J. Ploehn, and W.B. Russel Interactions between colloidal particles and soluble polymers Adv. Chem. Eng. 15 1990 137 228
58. X. Pu, J. Sun, M. Li, and Z. He Formulation of nanosuspensions as a new approach for the delivery of poorly soluble drugs Curr. Nanosci. 5 2009 417 427
59. B. Rabinow, J. Kipp, P. Papadopoulos, J. Wong, J. Glosson, J. Gass, C.S. Sun, T. Wielgos, R. White, C. Cook, K. Barker, and L. Wood Itraconazole IV nanosuspension enhances efficacy through altered pharmacokinetics in the rat Int. J. Pharm. 339 2007 251 260 (Pubitemid 46977603)
60. G.W. Radebaugh, J.L. Murtha, T.N. Julian, and J.N. Bondi Methods for evaluating the puncture and shear properties of pharmaceutical polymeric films Int. J. Pharm. 45 1988 39 46
61. J.W. Rhim, A. Gennadios, C.L. Weller, and M.A. Hanna Sodium dodecyl sulfate treatment improves properties of cast films from soy protein isolate Ind. Crop Prod. 15 2002 199 205 (Pubitemid 34231337)
62. M. Rodríguez, J. Osés, K. Ziani, and J.I. Maté Combined effect of plasticizers and surfactants on the physical properties of starch based edible films Food Res. Int. 39 2006 840 846 (Pubitemid 44163214)
63. Ryde, T., Gustow, E., Ruddy, S.B., Jain, R., Wilkins, M.J., 2007. Nanoparticulate fibrate formulations. US Patent 7,276,249.
64. Ryde, T., Gustow, E., Ruddy, S.B., Jain, R., Wilkins, M.J., 2008. Methods of treatment using nanoparticulate fenofibrate compositions. US Patent 7,320,802.
65. Sandal, R., Thakkar, V., Gundu, R.K., Dabre, R.S., Murali, N., Jain, G.K., 2011. Pharmaceutical compositions comprising adsorbate of fenofibrate. US Patent US 2011/097414 A1.
66. C. Schmidt, and R. Bodmeier Incorporation of polymeric nanoparticles into solid dosage forms J. Control. Release 57 1999 115 125 (Pubitemid 29062864)
67. R. Shegokar, and R.H. Müller Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives Int. J. Pharm. 399 2010 129 139
68. H. Shimoda, and K. Taniguchi Preparation of fast dissolving oral thin film containing dexamethasone: a possible application to antiemesis during cancer chemotherapy Eur. J. Pharm. Biopharm. Biopharm. 73 2009 361 365
69. G. Socrates Infrared and Raman Characteristic Group Frequencies 3rd ed. 2000 John Wiley & Sons, Ltd. England
70. Stamm, A., Seth, P., 2001. Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it. US Patent 6,277,405.
71. C. Timpe Drug solubilization strategies applying nanoparticulate formulation and solid dispersion approaches, drug development Pharm. Rev. 13 2010 12 21
72. B. Van Eerdenbrugh, G. Van den Mooter, and P. Augustijns Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products Int. J. Pharm. 364 2008 64 75
73. B. Van Eerdenbrugh, S. Vercruysse, J.A. Martens, J. Vermant, L. Froyen, G. Van Humbeeck, G. Van den Mooter, and P. Augustijns Microcrystalline cellulose, a useful alternative for sucrose as a matrix former during freeze-drying of drug nanosuspensions - a case study with itraconazole Eur. J. Pharm. Biopharm. 70 2008 590 596
74. B. Van Eerdenbrugh, L. Froyen, G. Van Humbeeck, J.A. Martens, P. Augustijns, and G. Van den Mooter Drying of crystalline drug nanosuspensions - the importance of surface hydrophobicity on dissolution behavior upon redispersion Eur. J. Pharm. Biopharm. 35 2008 127 135
75. B. Van Eerdenbrugh, J. Vermant, J.A. Martens, L. Froyen, J. Van Humbeeck, P. Augustijns, and G. Van demMooter A screening study of surface stabilization during the production of drug nanocrystals J. Pharm. Sci. 98 2009 2091 2103
76. G.J. Vergote, C. Nervaet, I. Van Driessche, S. Hoste, S. De Smedt, J. Demeester, R.A. Jain, S. Ruddy, and J.P. Remon An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen Int. J. Pharm. 219 2001 81 87 (Pubitemid 32391367)
77. S. Verma, S. Kumar, R. Gokhale, and D. Burgess Physical stability of nanosuspensions: investigation of the role of stabilizers on Ostwald ripening Int. J. Pharm. 15 2011 145 152
78. Yang, R.K., Fuisz, R.C., Myers, G.L., Fuisz, J.M., 2010. Method of making self-supporting therapeutic active-containing film. US Patent 7,824,588.
79. Yang, R.K., Fuisz, R.C., Myers, G.L., Fuisz, J.M., 2011. Process for forming an ingestible thin film with non-self-aggregating uniform heterogeneity. US Patent 7,910,031.
80. A. arów, B. Zhou, X. Wang, R. Pinal, and Z. Iqbal Spectroscopic and X-ray diffraction study of structural disorder in cryomilled and amorphous Griseofulvin Appl. Spectrosc. 65 2011 135 143